In cancer cells harbouring these TSC2 mutations, the TSC2-NTD/TSC2-GAP, or TSC1/TSC2, or TSC2-GAP/Rheb associations may be disrupted, leading to diminished GAP activity toward Rheb and abnormally elevated mTORC1 activity. This evidence concerns the gene RHEB and cancer.